跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 21,643 条关于
“China International Capital Corp”
全部
21,643
临床试验
10,120
药物
784
机构
1,107
资讯
9,632
去年
Innogen Pharmaceutical Soars 296% in Hong Kong Debut Following GLP-1 Diabetes Drug Approval
去年
Singapore Biotech Mirxes Achieves $1 Billion Valuation with Hong Kong IPO, Becomes First Southeast Asian Unicorn
2个月前
Jingze Bio Files Third HKEX IPO Application, Spotlighting Biosimilar Competition in China's Fertility and Ophthalmology Markets
2个月前
Zhenjiankang Medical's IPO Surge: How a Percutaneous Surgical Robotics Pioneer Achieved Three Accelerations in Eight Years
去年
AlphaGen Intelligence Corp Announces $195,000 Private Placement for Working Capital
5个月前
RA Capital Raises $75M Through Third SPAC Targeting China-Based Biotech Companies
去年
Simcere's Sublingual Edaravone Poised for Global Phase III Trial Following China Approval for Acute Ischemic Stroke
去年
Sanofi and Cathay Capital Launch $275M Fund for Clinical-Stage Drug Innovation in China
去年
bioAffinity Technologies Secures International Patents for CyPath Lung Cancer Diagnostic in China and Canada
去年
Pharmaessentia Corp. Advances with Phase III Clinical Trial for P1101 Targeting Pre-fibrotic/Early PMF
第 1 页，共 964 页
上一页
下一页
